Anavex Life Sciences Corp (AVXL)

[mixedup]

No. I went back and forth with ipulator_man a few days ago about this. He is right. There is P2a PART A and PART B (a.k.a. the "extension period").

P2a PART A will be completed by the end of the year. P2a PART B has already started for some of the patients. P2a PART B is scheduled for 26 weeks, but per the release of the P2a preliminary data, at the patients' request, the company is looking to extend that from 26 to 52 weeks.

If P2a PART A is scheduled to be completed by the end of the year, and at most P2a PART B will take 52 weeks, then all patients will have completed P2a by the end of next year, but it may take a while to gather final data.

P2b hasn't been designed yet. You can read more about P2a here:
http://www.anavex.com/wp-content/uploads/2015-07-22_Poster_AVXL_Phase_2a_AAIC_July_2015.pdf.